AGI AGI

 

TIDMAGI 
 
RNS Number : 0112H 
AGI Therapeutics plc 
11 February 2010 
 
 
 
                          AGI Therapeutics plc ('AGI') 
 
                               Holding in Company 
 
 
 
AGI was notified on 10 February 2010 that Edinburgh Partners Limited had 
decreased its shareholding to 2,569,576 Ordinary Shares representing 3.81% of 
AGI's Issued Share Capital. 
 
On 11 February 2010 AGI was notified that Edinburgh Partners Limited no longer 
had a notifiable interest in AGI's Issued Share Capital. 
 
 
 
Contact Information 
 
AGI Therapeutics 
 
David G. Kelly, Chief Financial Officer   Tel: +353 1 449 3254 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 HOLUAARRRSAUAAR 
 

AGI (LSE:AGI)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025

AGI (LSE:AGI)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025